Mitsubishi UFJ Asset Management
HZNP

Mitsubishi UFJ Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-90,598
Closed -$10.5M – 1603
2023
Q3 		$10.5M Buy
90,598
+5,939
+7% +$638K 0.02% 481
2023
Q2 		$8.71M Buy
84,659
+10,269
+14% +$1.08M 0.02% 514
2023
Q1 		$8.12M Buy
74,390
+3,783
+5% +$418K 0.02% 508
2022
Q4 		$8.01M Sell
70,607
-18,789
-21% -$1.56M 0.02% 487
2022
Q3 		$5.53M Sell
89,396
-79,494
-47% -$5.55M 0.02% 526
2022
Q2 		$13.5M Buy
168,890
+11,601
+7% +$1.1M 0.06% 322
2022
Q1 		$16.5M Buy
157,289
+13,112
+9% +$1.28M 0.07% 294
2021
Q4 		$15.6M Buy
144,177
+12,058
+9% +$1.32M 0.06% 319
2021
Q3 		$14.5M Buy
132,119
+2,322
+2% +$241K 0.07% 296
2021
Q2 		$12.2M Buy
129,797
+83,711
+182% +$7.7M 0.07% 327
2021
Q1 		$4.24M Buy
46,086
+4,304
+10% +$363K 0.03% 544
2020
Q4 		$3.06M Buy
+41,782
New +$3.11M 0.02% 563

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mitsubishi UFJ Asset Management's HZNP Position: Q4 2023 in Review

Mitsubishi UFJ Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 90,598 shares — an estimated $10.5M sold.

Mitsubishi UFJ Asset Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $16.5M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Mitsubishi UFJ Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 90,598 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $10.5M.
  • Mitsubishi UFJ Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Mitsubishi UFJ Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $16.5M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.